IBEX Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
IBEX Wealth Advisors's BMY Position: Q4 2021 in Review
IBEX Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 96 shares — an estimated $6K sold.
IBEX Wealth Advisors first reported a position in BMY in Q4 2016 and held it in 8 quarters. The position peaked at $5.72M in Q4 2020. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.
- IBEX Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
- IBEX Wealth Advisors sold 96 Bristol-Myers Squibb shares in Q4 2021, an estimated $6K.
- IBEX Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 8 quarters.
- IBEX Wealth Advisors's Bristol-Myers Squibb position peaked at $5.72M in Q4 2020.
- 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.
Based on IBEX Wealth Advisors's 13F filing for Q4 2021, filed 22 Feb 2022.